Paraneoplastic neurological syndromes of small cell lung cancer by Maedeh Barahman, Gholamreza Shamsaei, Davood Kashipazha, Mohammad Bahadoram, Esma’il Akade

Get full text

Emerging Role of PET in the Diagnosis and Staging of Lung Cancer by Geoffery Coates, Stephen J Skehan

“…Positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) has recently emerged as a practical and useful imaging modality in patients with lung cancer. Malignant tumours demonstrate increased uptake of FDG, a positron-emitting radiopharmaceutical. …”
Get full text

Are there social gradients in the occurrence of lung cancer and in the survival of lung cancer patients?... by Siegfried Geyer, Sebastian Schröder, Johannes Beller, Heiko Golpon

“…Objectives Only a few studies on health inequalities in terms of lung cancer are available. We examined whether social inequalities are present for the occurrence of lung cancer. …”
Get full text

PPARγ as a Novel Therapeutic Target in Lung Cancer by Aravind T. Reddy, Sowmya P. Lakshmi, Raju C. Reddy

“…Lung cancer is the leading cause of cancer-related death, with more than half the patients having advanced-stage disease at the time of initial diagnosis and thus facing a poor prognosis. …”
Get full text

Oligometastatic Disease at Presentation or Recurrence for Nonsmall Cell Lung Cancer by Daniel R. Gomez, Yuzuru Niibe, Joe Y. Chang

“…Oligometastatic Non-Small Cell Lung Cancer (NSCLC) presents a unique opportunity for potential curative therapy. …”
Get full text

Genetic and Biochemical Alterations in Non-Small Cell Lung Cancer by Jackie L. Johnson, Smitha Pillai, Srikumar P. Chellappan

“…Despite significant advances in the detection and treatment of lung cancer, it causes the highest number of cancer-related mortality. …”
Get full text

The therapeutic potential of RNA m(6)A in lung cancer by Jingran Yu, Wei Sun, Xiangxuan Zhao, Yingying Chen

Subjects: “…Lung cancer…”
Get full text

Blood-based DNA methylation markers for lung cancer prediction by Marc Chadeau-Hyam, Paolo Vineis, Caroline Relton, Mattias Johansson, Gianluca Severi, Roger L Milne, Melissa C Southey, Pierre-Antoine Dugué, Florence Guida, Mikael Johansson, Torkjel Sandanger, Justina Ucheojor Onwuka, Ryan Langdon, Therese Haugdahl Nøst, Hilary A. Robbins, Matthew Suderman

“…Objective Screening high-risk individuals with low-dose CT reduces mortality from lung cancer, but many lung cancers occur in individuals who are not eligible for screening. …”
Get full text

Behavior of Anemia due to Toxicity to Chemotherapy in Patients with Lung Cancer by Mahité Cañete Fonseca, Zaily Fuentes Díaz, Orlando Rodríguez Salazar

“…<br /><strong>Objective:</strong> to characterize the behavior of anemia due to toxicity to chemotherapy in patients with lung cancer.<strong> <br />Method:</strong> a descriptive and retrospective study was carried out in patients with lung cancer who received chemotherapy treatment at the María Curie Provincial Teaching Oncology Hospital in Camagüey province, from January 2020 to December 2022. …”
Get full text

Fractional Electrodamage in A549 Human Lung Cancer Cells by Hilario Martines-Arano, Jose Alberto Arano-Martinez, Manuel Alejandro Mosso-Pani, Alejandra Valdivia-Flores, Martin Trejo-Valdez, Blanca Estela García-Pérez, Carlos Torres-Torres

“…Fractional electrodamage in A549 human lung cancer cells was analyzed by introducing a non-integer order parameter to model the influence of electrical stimulation on cellular behavior. …”
Get full text

Research progress on the association between lung cancer and pulmonary embolism by Yi-Wen Zhang, Rui Tao, Dan Wu, Jin-Chun Ou, Zhuo-Chao Kong, Zhen-Zhen Zhu

Subjects: Get full text

Morphological and molecular genetic diagnosis of lung cancer: methods and problems by V. S. Usachev, E. I. Smolenov, Yu. A. Ragulin

Subjects: “…lung cancer…”
Get full text

An in-depth study of indolone derivatives as potential lung cancer treatment by Mohammed Er-rajy, Mohamed El fadili, Radwan Alnajjar, Sara Zarougui, Somdutt Mujwar, Khalil Azzaoui, Hatem A. Abuelizz, Belkheir Hammouti, Menana Elhallaoui

“…Abstract Lung cancer is a type of cancer that begins in the lungs and is one of the leading causes of cancer-related deaths worldwide. …”
Get full text

Exploration of the diagnostic and prognostic roles of decreased autoantibodies in lung cancer by Ying Ye, Ying Ye, Yi Huang, Yi Huang, Jianbo Pan, Jianbo Pan

Subjects: Get full text

New Lung Cancer Panel for High-Throughput Targeted Resequencing by Eun-Hye Kim, Sunghoon Lee, Jongsun Park, Kyusang Lee, Jong Bhak, Byung Chul Kim

“…We present a new next-generation sequencing-based method to identify somatic mutations of lung cancer. It is a comprehensive mutation profiling protocol to detect somatic mutations in 30 genes found frequently in lung adenocarcinoma. …”
Get full text

Conjunctival Metastasis as an Initial Sign of Small Cell Lung Cancer by Afsun Sahin, Nilgun Yildirim, Deniz Goren Sahin, Hikmet Basmak, Mustafa Acikalin

“…To report a case of a conjunctival metastasis as the initial manifestation of small cell lung cancer. Methods. Observational case report. Results. …”
Get full text

Integrated multiomics signatures to optimize the accurate diagnosis of lung cancer by Mengmeng Zhao, Gang Xue, Bingxi He, Jiajun Deng, Tingting Wang, Yifan Zhong, Shenghui Li, Yang Wang, Yiming He, Tao Chen, Jun Zhang, Ziyue Yan, Xinlei Hu, Liuning Guo, Wendong Qu, Yongxiang Song, Minglei Yang, Guofang Zhao, Bentong Yu, Minjie Ma, Lunxu Liu, Xiwen Sun, Yunlang She, Dan Xie, Deping Zhao, Chang Chen

“…Abstract Diagnosing lung cancer from indeterminate pulmonary nodules (IPLs) remains challenging. …”
Get full text

Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer by Mitchell S. von Itzstein, MD, Jialiang Liu, PhD, Hong Mu-Mosley, PhD, Farjana Fattah, PhD, Jason Y. Park, MD, PhD, Jeffrey A. SoRelle, MD, J. David Farrar, PhD, Mary E. Gwin, MD, David Hsiehchen, MD, Yvonne Gloria-McCutchen, Edward K. Wakeland, PhD, Suzanne Cole, MD, Sheena Bhalla, MD, Radhika Kainthla, MD, Igor Puzanov, MD, MSCI, Benjamin Switzer, DO, MHSA, MS, Gregory A. Daniels, MD, PhD, Yousef Zakharia, MD, Montaser Shaheen, MD, Jianjun Zhang, MD, PhD, Yang Xie, PhD, David E. Gerber, MD

Subjects: Get full text

Metastatic Ureteral Involvement of Non-Small Cell Lung Cancer by Koichi Kodama, Tetsuya Imao, Kazuto Komatsu

“…Metastases from a variety of malignant tumors can involve the ureters, but ureteral involvement by lung cancer is extremely rare and usually described at autopsy. …”
Get full text

Discovery and Evaluation of Polymorphisms in the and Promoter Regions for Risk of Korean Lung Cancer by Jae Sook Sung, Kyong Hwa Park, Seung Tae Kim, Yeul Hong Kim

“…We first discovered 2 novel polymorphisms (AKT2 -9826 C/G and AKT3 -811 A/G), and we confirmed 6 known polymorphisms (AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, AKT3 -675 A/-, and AKT3 -244 C/T) of the AKT2 and AKT3 promoter region in 24 blood samples of Korean lung cancer patients using direct sequencing. To evaluate the role of AKT2 and AKT3 polymorphisms in the risk of Korean lung cancer, genotypes of the AKT2 and AKT3 polymorphisms (AKT2 -9826 C/G, AKT2 -9473 C/T, AKT2 -9151 C/T, AKT2 -9025 C/T, AKT2 -8618G/A, and AKT3 -675 A/-) were determined in 360 lung cancer patients and 360 normal controls. …”
Get full text